Dimensional Fund Advisors LP Xenon Pharmaceuticals Inc. Transaction History

Dimensional Fund Advisors LP

  • $418 Billion
  • Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 379,988 shares of XENE stock, worth $15.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
379,988
Previous 214,860 76.85%
Holding current value
$15.1 Million
Previous $7.21 Million 65.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$28.23 - $38.37 $4.66 Million - $6.34 Million
165,128 Added 76.85%
379,988 $11.9 Million
Q1 2025

May 13, 2025
SELL
$33.55 - $40.74 $1.51 Million - $1.84 Million
-45,110 Reduced 17.35%
214,860 $7.21 Million
Q4 2024

Feb 13, 2025
SELL
$38.14 - $45.74 $1.52 Million - $1.82 Million
-39,895 Reduced 13.3%
259,970 $10.2 Million
Q3 2024

Nov 07, 2024
SELL
$36.12 - $43.96 $4.93 Million - $6 Million
-136,595 Reduced 31.3%
299,865 $11.8 Million
Q2 2024

Aug 09, 2024
BUY
$36.25 - $43.75 $951,671 - $1.15 Million
26,253 Added 6.4%
436,460 $17 Million
Q1 2024

May 10, 2024
BUY
$42.66 - $50.04 $321,613 - $377,251
7,539 Added 1.87%
410,207 $17.7 Million
Q4 2023

Feb 07, 2024
SELL
$28.7 - $46.46 $701,915 - $1.14 Million
-24,457 Reduced 5.73%
402,668 $18.5 Million
Q3 2023

Nov 09, 2023
BUY
$34.16 - $39.73 $5.64 Million - $6.56 Million
165,018 Added 62.96%
427,125 $14.6 Million
Q2 2023

Aug 09, 2023
BUY
$34.84 - $43.54 $6.86 Million - $8.57 Million
196,841 Added 301.6%
262,107 $10.1 Million
Q1 2023

May 12, 2023
SELL
$33.46 - $40.35 $8.35 Million - $10.1 Million
-249,407 Reduced 79.26%
65,266 $2.34 Million
Q4 2022

Feb 09, 2023
SELL
$33.06 - $39.43 $904,455 - $1.08 Million
-27,358 Reduced 8.0%
314,673 $12.4 Million
Q3 2022

Nov 10, 2022
BUY
$30.79 - $39.82 $5.14 Million - $6.65 Million
167,069 Added 95.49%
342,031 $12.3 Million
Q2 2022

Aug 12, 2022
SELL
$25.44 - $35.16 $3.02 Million - $4.18 Million
-118,767 Reduced 40.43%
174,962 $5.32 Million
Q1 2022

May 13, 2022
BUY
$25.09 - $33.13 $44,735 - $59,070
1,783 Added 0.61%
293,729 $8.98 Million
Q4 2021

Feb 09, 2022
BUY
$15.6 - $35.4 $2.2 Million - $4.98 Million
140,749 Added 93.09%
291,946 $9.12 Million
Q3 2021

Nov 12, 2021
BUY
$14.86 - $19.45 $2.02 Million - $2.65 Million
136,187 Added 907.31%
151,197 $2.31 Million
Q2 2021

Aug 12, 2021
BUY
$16.81 - $20.0 $252,318 - $300,200
15,010 New
15,010 $279,000

Others Institutions Holding XENE

# of Institutions
221
Shares Held
72.7M
Call Options Held
336K
Put Options Held
309K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.47B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email